{"transactions":[{"id":1919143,"issuer":{"id":135,"kind":"organization","name":"Grove Collaborative Holdings, Inc.","symbol":"GROV"},"owners":[{"id":105623,"kind":"organization","name":"Norwest Venture Partners XIII, LP","position":1,"cik":"0001772583","reported_name":"Norwest Venture Partners XIII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":99572,"kind":"organization","name":"NVP ASSOCIATES, LLC","position":2,"cik":"0001545692","reported_name":"NVP Associates, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":3,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114424,"kind":"person","name":"HAQUE PROMOD","position":4,"cik":"0001089744","reported_name":"HAQUE PROMOD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":5,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2023-04-17T21:18:50.000Z","date":"2023-04-13","kind":"other","planned":false,"acquired":true,"shares":135480,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Norwest Venture Partners XIII, LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis for no additional consideration at the Reporting Person's election and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents the automatic increase, for no additional consideration, in the number of shares of Class B Common Stock held by the Reporting Person as a result of the rebalancing of Earnout Shares following the forfeiture of certain equity awards of the Issuer by the holders thereof, as required by the Agreement and Plan of Merger, dated December 7, 2021, as amended and restated on March 31, 2022, by and among Virgin Group Acquisition Corp. II (\"VGAC II\"), two wholly owned direct subsidiaries of VGAC II, and Grove Collaborative, Inc.  This increase is exempt from Section 16 filing by virtue of the exemption provided by Rule 16a-9 and is being reported voluntarily."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis for no additional consideration at the Reporting Person's election and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis for no additional consideration at the Reporting Person's election and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis for no additional consideration at the Reporting Person's election and has no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Represents restricted shares of Class B Common Stock that will vest upon the achievement of certain earnout thresholds prior to June 16, 2032 (the \"Earnout Shares\") as follows: (i) 50% of the Earnout Shares automatically vest if the daily volume weighted average price (\"VWAP\") of the shares of Class A Common Stock is greater than or equal to $12.50 per share for any 20 trading days within any 30-trading-day period; and (ii) 50% of the Earnout Shares automatically vest if the daily VWAP of the shares of Class A Common Stock is greater than or equal to $15.00 per share for any 20 trading days within any 30-trading-day period, each subject to certain change-of-control provisions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by Norwest Venture Partners XIII, LP (\"NVP XIII\"). Genesis VC Partners XIII, LLC (\"Genesis XIII\") is the general partner of NVP XIII and NVP Associates, LLC (\"NVP Associates\") is the managing member of Genesis XIII. Genesis XIII, NVP Associates and Jeffrey Crowe, Promod Haque and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power over the shares held by NVP XIII. Each of Genesis XIII, NVP Associates and Messrs. Crowe, Haque and Kossow disclaims beneficial ownership of the securities held by NVP XIII except to the extent of its or his pecuniary interest therein."}],"balance_after":1407876,"derivative":{"underlying":"Class A Common Stock","underlying_shares":135480},"source":{"system":"sec-edgar","filing":"0001209191-23-024567","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1089744/000120919123024567/doc4.xml","form_type":"4"}},{"id":1919142,"issuer":{"id":135,"kind":"organization","name":"Grove Collaborative Holdings, Inc.","symbol":"GROV"},"owners":[{"id":105623,"kind":"organization","name":"Norwest Venture Partners XIII, LP","position":1,"cik":"0001772583","reported_name":"Norwest Venture Partners XIII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":99572,"kind":"organization","name":"NVP ASSOCIATES, LLC","position":2,"cik":"0001545692","reported_name":"NVP Associates, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":3,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114424,"kind":"person","name":"HAQUE PROMOD","position":4,"cik":"0001089744","reported_name":"HAQUE PROMOD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":5,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2023-04-17T21:18:50.000Z","date":"2022-11-23","kind":"exercise","planned":false,"acquired":false,"shares":14217512,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Norwest Venture Partners XIII, LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These shares of Class B common stock were converted into Class A common stock on a one-for-one basis for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis for no additional consideration at the Reporting Person's election and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis for no additional consideration at the Reporting Person's election and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis for no additional consideration at the Reporting Person's election and has no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Represents restricted shares of Class B Common Stock that will vest upon the achievement of certain earnout thresholds prior to June 16, 2032 (the \"Earnout Shares\") as follows: (i) 50% of the Earnout Shares automatically vest if the daily volume weighted average price (\"VWAP\") of the shares of Class A Common Stock is greater than or equal to $12.50 per share for any 20 trading days within any 30-trading-day period; and (ii) 50% of the Earnout Shares automatically vest if the daily VWAP of the shares of Class A Common Stock is greater than or equal to $15.00 per share for any 20 trading days within any 30-trading-day period, each subject to certain change-of-control provisions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by Norwest Venture Partners XIII, LP (\"NVP XIII\"). Genesis VC Partners XIII, LLC (\"Genesis XIII\") is the general partner of NVP XIII and NVP Associates, LLC (\"NVP Associates\") is the managing member of Genesis XIII. Genesis XIII, NVP Associates and Jeffrey Crowe, Promod Haque and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power over the shares held by NVP XIII. Each of Genesis XIII, NVP Associates and Messrs. Crowe, Haque and Kossow disclaims beneficial ownership of the securities held by NVP XIII except to the extent of its or his pecuniary interest therein."}],"balance_after":1272396,"derivative":{"underlying":"Class A Common Stock","underlying_shares":14217512},"source":{"system":"sec-edgar","filing":"0001209191-23-024567","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1089744/000120919123024567/doc4.xml","form_type":"4"}},{"id":1919141,"issuer":{"id":135,"kind":"organization","name":"Grove Collaborative Holdings, Inc.","symbol":"GROV"},"owners":[{"id":105623,"kind":"organization","name":"Norwest Venture Partners XIII, LP","position":1,"cik":"0001772583","reported_name":"Norwest Venture Partners XIII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":99572,"kind":"organization","name":"NVP ASSOCIATES, LLC","position":2,"cik":"0001545692","reported_name":"NVP Associates, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":3,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114424,"kind":"person","name":"HAQUE PROMOD","position":4,"cik":"0001089744","reported_name":"HAQUE PROMOD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":5,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-04-17T21:18:50.000Z","date":"2022-11-23","kind":"exercise","planned":false,"acquired":true,"shares":14217512,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Norwest Venture Partners XIII, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of Class B common stock were converted into Class A common stock on a one-for-one basis for no additional consideration."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are directly held by Norwest Venture Partners XIII, LP (\"NVP XIII\"). Genesis VC Partners XIII, LLC (\"Genesis XIII\") is the general partner of NVP XIII and NVP Associates, LLC (\"NVP Associates\") is the managing member of Genesis XIII. Genesis XIII, NVP Associates and Jeffrey Crowe, Promod Haque and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power over the shares held by NVP XIII. Each of Genesis XIII, NVP Associates and Messrs. Crowe, Haque and Kossow disclaims beneficial ownership of the securities held by NVP XIII except to the extent of its or his pecuniary interest therein."}],"balance_after":14717612,"source":{"system":"sec-edgar","filing":"0001209191-23-024567","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1089744/000120919123024567/doc4.xml","form_type":"4"}},{"id":2529599,"issuer":{"id":47614,"kind":"organization","name":"Udemy, Inc.","symbol":"UDMY"},"owners":[{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":1,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":99572,"kind":"organization","name":"NVP ASSOCIATES, LLC","position":2,"cik":"0001545692","reported_name":"NVP Associates, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":3,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114424,"kind":"person","name":"HAQUE PROMOD","position":4,"cik":"0001089744","reported_name":"HAQUE PROMOD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":5,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D  Convertible Preferred Stock","published_at":"2021-11-02T19:00:27.000Z","date":"2021-11-02","kind":"exercise","acquired":false,"shares":1418858,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series D Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series D Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series D Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series D Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by Norwest Venture Partners XII, LP. Genesis VC Partners XII, LLC is the general partner of Norwest Venture Partners XII, LP, and NVP Associates, LLC is the managing member of Genesis VC Partners XII, LLC. Each of Promod Haque, Jeffrey Crowe, and Jon Kossow, who are co-chief executive officers of NVP Associates, LLC, may be deemed to share voting and dispositive power over the shares held by Norwest Venture Partners XII, LP. Each of the reporting entities and individuals disclaims beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1418858},"source":{"system":"sec-edgar","filing":"0000899243-21-042450","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1089744/000089924321042450/doc4.xml","form_type":"4"}},{"id":2529598,"issuer":{"id":47614,"kind":"organization","name":"Udemy, Inc.","symbol":"UDMY"},"owners":[{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":1,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":99572,"kind":"organization","name":"NVP ASSOCIATES, LLC","position":2,"cik":"0001545692","reported_name":"NVP Associates, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":3,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114424,"kind":"person","name":"HAQUE PROMOD","position":4,"cik":"0001089744","reported_name":"HAQUE PROMOD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":5,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2021-11-02T19:00:27.000Z","date":"2021-11-02","kind":"exercise","acquired":false,"shares":10134082,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by Norwest Venture Partners XII, LP. Genesis VC Partners XII, LLC is the general partner of Norwest Venture Partners XII, LP, and NVP Associates, LLC is the managing member of Genesis VC Partners XII, LLC. Each of Promod Haque, Jeffrey Crowe, and Jon Kossow, who are co-chief executive officers of NVP Associates, LLC, may be deemed to share voting and dispositive power over the shares held by Norwest Venture Partners XII, LP. Each of the reporting entities and individuals disclaims beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":10134082},"source":{"system":"sec-edgar","filing":"0000899243-21-042450","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1089744/000089924321042450/doc4.xml","form_type":"4"}},{"id":2529597,"issuer":{"id":47614,"kind":"organization","name":"Udemy, Inc.","symbol":"UDMY"},"owners":[{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":1,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":99572,"kind":"organization","name":"NVP ASSOCIATES, LLC","position":2,"cik":"0001545692","reported_name":"NVP Associates, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":3,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114424,"kind":"person","name":"HAQUE PROMOD","position":4,"cik":"0001089744","reported_name":"HAQUE PROMOD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":5,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-11-02T19:00:27.000Z","date":"2021-11-02","kind":"exercise","acquired":true,"shares":11552940,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series D Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by Norwest Venture Partners XII, LP. Genesis VC Partners XII, LLC is the general partner of Norwest Venture Partners XII, LP, and NVP Associates, LLC is the managing member of Genesis VC Partners XII, LLC. Each of Promod Haque, Jeffrey Crowe, and Jon Kossow, who are co-chief executive officers of NVP Associates, LLC, may be deemed to share voting and dispositive power over the shares held by Norwest Venture Partners XII, LP. Each of the reporting entities and individuals disclaims beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":12458934,"source":{"system":"sec-edgar","filing":"0000899243-21-042450","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1089744/000089924321042450/doc4.xml","form_type":"4"}},{"id":2736265,"issuer":{"id":15659,"kind":"organization","name":"IPI Legacy Liquidation Co","symbol":"IMPLQ"},"owners":[{"id":105970,"kind":"organization","name":"NORWEST VENTURE PARTNERS XIV, LP","position":1,"cik":"0001842721","reported_name":"Norwest Venture Partners XIV, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":2,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114424,"kind":"person","name":"HAQUE PROMOD","position":3,"cik":"0001089744","reported_name":"HAQUE PROMOD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":4,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Preferred Stock","published_at":"2021-04-29T19:45:05.000Z","date":"2021-04-27","kind":"exercise","acquired":false,"shares":35256206,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The securities shown represent securities held of record by Norwest Venture Partners XIV, LP (\"NVP XIV\"). Genesis VC Partners XIV, LLC (\"Genesis XIV\") is the general partner of NVP XIV and may be deemed to have sole voting and dispositive power over the shares held by NVP XIV. NVP Associates, LLC (\"NVP Associates\"), the managing member of Genesis XIV, and Jeffrey Crowe, Promod Haque and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities and Messrs. Crowe, Haque and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The shares of the Issuer's Series D Preferred Stock automatically converted into the number of shares of the Issuer's Common Stock on a 16.37332-for-one basis, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of Common Stock (the \"IPO\") and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of the Issuer's Series D Preferred Stock automatically converted into the number of shares of the Issuer's Common Stock on a 16.37332-for-one basis, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of Common Stock (the \"IPO\") and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares of the Issuer's Series D Preferred Stock automatically converted into the number of shares of the Issuer's Common Stock on a 16.37332-for-one basis, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of Common Stock (the \"IPO\") and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2153271},"source":{"system":"sec-edgar","filing":"0001209191-21-029115","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1089744/000120919121029115/doc4.xml","form_type":"4"}},{"id":2736264,"issuer":{"id":15659,"kind":"organization","name":"IPI Legacy Liquidation Co","symbol":"IMPLQ"},"owners":[{"id":105970,"kind":"organization","name":"NORWEST VENTURE PARTNERS XIV, LP","position":1,"cik":"0001842721","reported_name":"Norwest Venture Partners XIV, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":2,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114424,"kind":"person","name":"HAQUE PROMOD","position":3,"cik":"0001089744","reported_name":"HAQUE PROMOD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":4,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"5% Convertible Note due 2021","published_at":"2021-04-29T19:45:05.000Z","date":"2021-04-27","kind":"exercise","acquired":false,"price":0,"reported_value":1325893.04,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The securities shown represent securities held of record by Norwest Venture Partners XIV, LP (\"NVP XIV\"). Genesis VC Partners XIV, LLC (\"Genesis XIV\") is the general partner of NVP XIV and may be deemed to have sole voting and dispositive power over the shares held by NVP XIV. NVP Associates, LLC (\"NVP Associates\"), the managing member of Genesis XIV, and Jeffrey Crowe, Promod Haque and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities and Messrs. Crowe, Haque and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The convertible promissory note was issued by the Issuer in March 2021 and the outstanding principal and accrued interest automatically converted into the number of shares of the Issuer's Common Stock set forth above upon the closing of the IPO at $13.50 per share (90% of the IPO price)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The convertible promissory note was issued by the Issuer in March 2021 and the outstanding principal and accrued interest automatically converted into the number of shares of the Issuer's Common Stock set forth above upon the closing of the IPO at $13.50 per share (90% of the IPO price)."}],"balance_after":0,"derivative":{"exercise_price":13.5,"expiration_date":"2021-12-31","underlying":"Common Stock","underlying_shares":98927},"source":{"system":"sec-edgar","filing":"0001209191-21-029115","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1089744/000120919121029115/doc4.xml","form_type":"4"}},{"id":2736263,"issuer":{"id":15659,"kind":"organization","name":"IPI Legacy Liquidation Co","symbol":"IMPLQ"},"owners":[{"id":105970,"kind":"organization","name":"NORWEST VENTURE PARTNERS XIV, LP","position":1,"cik":"0001842721","reported_name":"Norwest Venture Partners XIV, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":2,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114424,"kind":"person","name":"HAQUE PROMOD","position":3,"cik":"0001089744","reported_name":"HAQUE PROMOD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":4,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-04-29T19:45:05.000Z","date":"2021-04-27","kind":"purchase","acquired":true,"shares":825000,"price":15,"value":12375000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The securities shown represent securities held of record by Norwest Venture Partners XIV, LP (\"NVP XIV\"). Genesis VC Partners XIV, LLC (\"Genesis XIV\") is the general partner of NVP XIV and may be deemed to have sole voting and dispositive power over the shares held by NVP XIV. NVP Associates, LLC (\"NVP Associates\"), the managing member of Genesis XIV, and Jeffrey Crowe, Promod Haque and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities and Messrs. Crowe, Haque and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."}],"balance_after":3077198,"source":{"system":"sec-edgar","filing":"0001209191-21-029115","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1089744/000120919121029115/doc4.xml","form_type":"4"}},{"id":2736262,"issuer":{"id":15659,"kind":"organization","name":"IPI Legacy Liquidation Co","symbol":"IMPLQ"},"owners":[{"id":105970,"kind":"organization","name":"NORWEST VENTURE PARTNERS XIV, LP","position":1,"cik":"0001842721","reported_name":"Norwest Venture Partners XIV, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":2,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114424,"kind":"person","name":"HAQUE PROMOD","position":3,"cik":"0001089744","reported_name":"HAQUE PROMOD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":4,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-04-29T19:45:05.000Z","date":"2021-04-27","kind":"exercise","acquired":true,"shares":2153271,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The securities shown represent securities held of record by Norwest Venture Partners XIV, LP (\"NVP XIV\"). Genesis VC Partners XIV, LLC (\"Genesis XIV\") is the general partner of NVP XIV and may be deemed to have sole voting and dispositive power over the shares held by NVP XIV. NVP Associates, LLC (\"NVP Associates\"), the managing member of Genesis XIV, and Jeffrey Crowe, Promod Haque and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities and Messrs. Crowe, Haque and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of the Issuer's Series D Preferred Stock automatically converted into the number of shares of the Issuer's Common Stock on a 16.37332-for-one basis, for no additional consideration, immediately prior to the closing of the Issuer's initial public offering of Common Stock (the \"IPO\") and had no expiration date."}],"balance_after":2252198,"source":{"system":"sec-edgar","filing":"0001209191-21-029115","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1089744/000120919121029115/doc4.xml","form_type":"4"}},{"id":2736261,"issuer":{"id":15659,"kind":"organization","name":"IPI Legacy Liquidation Co","symbol":"IMPLQ"},"owners":[{"id":105970,"kind":"organization","name":"NORWEST VENTURE PARTNERS XIV, LP","position":1,"cik":"0001842721","reported_name":"Norwest Venture Partners XIV, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":2,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114424,"kind":"person","name":"HAQUE PROMOD","position":3,"cik":"0001089744","reported_name":"HAQUE PROMOD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":4,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-04-29T19:45:05.000Z","date":"2021-04-27","kind":"exercise","acquired":true,"shares":98927,"price":13.5,"value":1335514.5,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The securities shown represent securities held of record by Norwest Venture Partners XIV, LP (\"NVP XIV\"). Genesis VC Partners XIV, LLC (\"Genesis XIV\") is the general partner of NVP XIV and may be deemed to have sole voting and dispositive power over the shares held by NVP XIV. NVP Associates, LLC (\"NVP Associates\"), the managing member of Genesis XIV, and Jeffrey Crowe, Promod Haque and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities and Messrs. Crowe, Haque and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."}],"balance_after":98927,"source":{"system":"sec-edgar","filing":"0001209191-21-029115","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1089744/000120919121029115/doc4.xml","form_type":"4"}},{"id":2739894,"issuer":{"id":15659,"kind":"organization","name":"IPI Legacy Liquidation Co","symbol":"IMPLQ"},"owners":[{"id":105970,"kind":"organization","name":"NORWEST VENTURE PARTNERS XIV, LP","position":1,"cik":"0001842721","reported_name":"Norwest Venture Partners XIV, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":2,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114424,"kind":"person","name":"HAQUE PROMOD","position":3,"cik":"0001089744","reported_name":"HAQUE PROMOD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":4,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"5% Convertible Note due 2021","published_at":"2021-04-26T19:02:06.000Z","date":"2021-04-22","kind":"other","acquired":true,"price":0,"reported_value":1325893.04,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The convertible promissory note was issued by the issuer in March 2021 and the outstanding principal and accrued interest will automatically convert into the number of shares of the issuer's Common Stock set forth above upon the closing of the issuer's initial public offering (the \"IPO\") at $13.50 per share (90% of the IPO price). The conversion price became fixed upon pricing of the issuer's IPO on April 22, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The convertible promissory note was issued by the issuer in March 2021 and the outstanding principal and accrued interest will automatically convert into the number of shares of the issuer's Common Stock set forth above upon the closing of the issuer's initial public offering (the \"IPO\") at $13.50 per share (90% of the IPO price). The conversion price became fixed upon pricing of the issuer's IPO on April 22, 2021."}],"derivative":{"expiration_date":"2021-12-31","underlying":"Common Stock","underlying_shares":98927},"source":{"system":"sec-edgar","filing":"0001209191-21-028401","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1089744/000120919121028401/doc4.xml","form_type":"4"}},{"id":3080135,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":106341,"kind":"organization","name":"NORWEST VENTURE PARTNERS XI, LP","position":1,"cik":"0001534522","reported_name":"Norwest Venture Partners XI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":2,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":3,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":4,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-17T18:00:27.000Z","date":"2020-07-15","kind":"other","acquired":false,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Limited Partnership"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Shares were disposed of via a pro rata in-kind distribution of Issuer's stock from Norwest Venture Partners XII, LP (\"NVP XII\") to its limited partners."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares were disposed of via a pro rata in-kind distribution of Issuer's stock from Norwest Venture Partners XII, LP (\"NVP XII\") to its limited partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities shown on Line 2 of Table I represent securities held of record by NVP XII. Genesis VC Partners XII, LLC (\"Genesis XII\") is the general partner of NVP XII and may be deemed to have sole voting and dispositive power over the shares held by NVP XII. NVP Associates, the managing member of Genesis XII, and Jeffrey Crowe and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities, Crowe and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."}],"balance_after":1752090,"source":{"system":"sec-edgar","filing":"0001209191-20-042940","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534522/000120919120042940/doc4.xml","form_type":"4"}},{"id":3080134,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":106341,"kind":"organization","name":"NORWEST VENTURE PARTNERS XI, LP","position":1,"cik":"0001534522","reported_name":"Norwest Venture Partners XI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":2,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":3,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":4,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-17T18:00:27.000Z","date":"2020-07-15","kind":"other","acquired":false,"shares":599939,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were disposed of via a pro rata in-kind distribution of Issuer's stock from Norwest Venture Partners XI, LP (\"NVP XI\") to its limited partners."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares were disposed of via a pro rata in-kind distribution of Issuer's stock from Norwest Venture Partners XI, LP (\"NVP XI\") to its limited partners."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The NVP XI distribution resulted in a change in the form of beneficial ownership so that following the distribution 123 shares were beneficially owned by Kossow Family Trust, of which Mr. Kossow is a Trustee. The remaining 1,752,091 shares are held of record by NVP XI. Genesis VC Partners XI, LLC (\"Genesis XI\") is the general partner of NVP XI and may be deemed to have sole voting and dispositive power over the shares held by NVP XI. NVP Associates, LLC (\"NVP Associates\"), the managing member of Genesis XI, and Jeffrey Crowe and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities, Crowe and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."}],"balance_after":1752214,"source":{"system":"sec-edgar","filing":"0001209191-20-042940","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534522/000120919120042940/doc4.xml","form_type":"4"}},{"id":3303775,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":106341,"kind":"organization","name":"NORWEST VENTURE PARTNERS XI, LP","position":1,"cik":"0001534522","reported_name":"Norwest Venture Partners XI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":2,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":3,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":4,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-23T17:30:44.000Z","date":"2020-01-21","kind":"other","acquired":false,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Limited Partnership"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Shares were disposed of via a pro rata in-kind distribution of Issuer's stock from Norwest Venture Partners XII, LP (\"NVP XII\") to its limited partners."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Shares were disposed of via a pro rata in-kind distribution of Issuer's stock from Norwest Venture Partners XII, LP (\"NVP XII\") to its limited partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The securities shown on Line 2 of Table I represent securities held of record by NVP XII. Genesis VC Partners XII, LLC (\"Genesis XII\") is the general partner of NVP XII and may be deemed to have sole voting and dispositive power over the shares held by NVP XII. NVP Associates, the managing member of Genesis XII, and Jeffrey Crowe and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities, Crowe and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."}],"balance_after":2352090,"source":{"system":"sec-edgar","filing":"0001209191-20-004714","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534522/000120919120004714/doc4.xml","form_type":"4"}},{"id":3303774,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":106341,"kind":"organization","name":"NORWEST VENTURE PARTNERS XI, LP","position":1,"cik":"0001534522","reported_name":"Norwest Venture Partners XI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":2,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":3,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":4,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-23T17:30:44.000Z","date":"2020-01-21","kind":"other","acquired":false,"shares":599938,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were disposed of via a pro rata in-kind distribution of Issuer's stock from Norwest Venture Partners XI, LP (\"NVP XI\") to its limited partners."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares were disposed of via a pro rata in-kind distribution of Issuer's stock from Norwest Venture Partners XI, LP (\"NVP XI\") to its limited partners."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The NVP XI distribution resulted in a change in the form of beneficial ownership so that following the distribution 62 shares were beneficially owned by Kossow Family Trust, of which Mr. Kossow is a Trustee. The remaining 2,352,091 shares are held of record by NVP XI. Genesis VC Partners XI, LLC (\"Genesis XI\") is the general partner of NVP XI and may be deemed to have sole voting and dispositive power over the shares held by NVP XI. NVP Associates, LLC (\"NVP Associates\"), the managing member of Genesis XI, and Jeffrey Crowe and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities, Crowe and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."}],"balance_after":2352153,"source":{"system":"sec-edgar","filing":"0001209191-20-004714","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534522/000120919120004714/doc4.xml","form_type":"4"}},{"id":3454151,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":106341,"kind":"organization","name":"NORWEST VENTURE PARTNERS XI, LP","position":1,"cik":"0001534522","reported_name":"Norwest Venture Partners XI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":2,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":3,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":4,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series F Convertible Preferred Stock","published_at":"2019-07-29T21:02:26.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":35919,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Limited Partnership"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The Series F Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The Series F Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Series F Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The securities shown on Line 2 of Table I and Lines 6 through 10 of Table II represent securities held of record by Norwest Venture Partners XII, LP (\"NVP XII\"). Genesis VC Partners XII, LLC (\"Genesis XII\") is the general partner of NVP XII and may be deemed to have sole voting and dispositive power over the shares held by NVP XII. NVP Associates, LLC (\"NVP Associates\"), the managing member of Genesis XII, and Jeffrey Crowe and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities, Crowe and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":35919},"source":{"system":"sec-edgar","filing":"0001209191-19-043590","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1534522/000120919119043590/doc4.xml","form_type":"4"}},{"id":3454150,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":106341,"kind":"organization","name":"NORWEST VENTURE PARTNERS XI, LP","position":1,"cik":"0001534522","reported_name":"Norwest Venture Partners XI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":2,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":3,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":4,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E Convertible Preferred Stock","published_at":"2019-07-29T21:02:26.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":424568,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Limited Partnership"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The securities shown on Line 2 of Table I and Lines 6 through 10 of Table II represent securities held of record by Norwest Venture Partners XII, LP (\"NVP XII\"). Genesis VC Partners XII, LLC (\"Genesis XII\") is the general partner of NVP XII and may be deemed to have sole voting and dispositive power over the shares held by NVP XII. NVP Associates, LLC (\"NVP Associates\"), the managing member of Genesis XII, and Jeffrey Crowe and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities, Crowe and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":424568},"source":{"system":"sec-edgar","filing":"0001209191-19-043590","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1534522/000120919119043590/doc4.xml","form_type":"4"}},{"id":3454149,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":106341,"kind":"organization","name":"NORWEST VENTURE PARTNERS XI, LP","position":1,"cik":"0001534522","reported_name":"Norwest Venture Partners XI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":2,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":3,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":4,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Convertible Preferred Stock","published_at":"2019-07-29T21:02:26.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":471831,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Limited Partnership"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The securities shown on Line 2 of Table I and Lines 6 through 10 of Table II represent securities held of record by Norwest Venture Partners XII, LP (\"NVP XII\"). Genesis VC Partners XII, LLC (\"Genesis XII\") is the general partner of NVP XII and may be deemed to have sole voting and dispositive power over the shares held by NVP XII. NVP Associates, LLC (\"NVP Associates\"), the managing member of Genesis XII, and Jeffrey Crowe and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities, Crowe and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":471831},"source":{"system":"sec-edgar","filing":"0001209191-19-043590","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1534522/000120919119043590/doc4.xml","form_type":"4"}},{"id":3454148,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":106341,"kind":"organization","name":"NORWEST VENTURE PARTNERS XI, LP","position":1,"cik":"0001534522","reported_name":"Norwest Venture Partners XI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":2,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":3,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":4,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2019-07-29T21:02:26.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":577045,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Limited Partnership"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The securities shown on Line 2 of Table I and Lines 6 through 10 of Table II represent securities held of record by Norwest Venture Partners XII, LP (\"NVP XII\"). Genesis VC Partners XII, LLC (\"Genesis XII\") is the general partner of NVP XII and may be deemed to have sole voting and dispositive power over the shares held by NVP XII. NVP Associates, LLC (\"NVP Associates\"), the managing member of Genesis XII, and Jeffrey Crowe and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities, Crowe and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":577045},"source":{"system":"sec-edgar","filing":"0001209191-19-043590","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1534522/000120919119043590/doc4.xml","form_type":"4"}},{"id":3454147,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":106341,"kind":"organization","name":"NORWEST VENTURE PARTNERS XI, LP","position":1,"cik":"0001534522","reported_name":"Norwest Venture Partners XI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":2,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":3,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":4,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2019-07-29T21:02:26.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":1442727,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Limited Partnership"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Series B Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series B Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series B Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The securities shown on Line 2 of Table I and Lines 6 through 10 of Table II represent securities held of record by Norwest Venture Partners XII, LP (\"NVP XII\"). Genesis VC Partners XII, LLC (\"Genesis XII\") is the general partner of NVP XII and may be deemed to have sole voting and dispositive power over the shares held by NVP XII. NVP Associates, LLC (\"NVP Associates\"), the managing member of Genesis XII, and Jeffrey Crowe and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities, Crowe and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1442727},"source":{"system":"sec-edgar","filing":"0001209191-19-043590","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1534522/000120919119043590/doc4.xml","form_type":"4"}},{"id":3454146,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":106341,"kind":"organization","name":"NORWEST VENTURE PARTNERS XI, LP","position":1,"cik":"0001534522","reported_name":"Norwest Venture Partners XI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":2,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":3,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":4,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series F Convertible Preferred Stock","published_at":"2019-07-29T21:02:26.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":35919,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The securities shown on Line 1 of Table I and Lines 1 through 5 of Table II represent securities held of record by Norwest Venture Partners XI, LP (\"NVP XI\"). Genesis VC Partners XI, LLC (\"Genesis XI\") is the general partner of NVP XI and may be deemed to have sole voting and dispositive power over the shares held by NVP XI. NVP Associates, LLC (\"NVP Associates\"), the managing member of Genesis XI, and Jeffrey Crowe and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities, Crowe and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"The Series F Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The Series F Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Series F Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":35919},"source":{"system":"sec-edgar","filing":"0001209191-19-043590","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1534522/000120919119043590/doc4.xml","form_type":"4"}},{"id":3454145,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":106341,"kind":"organization","name":"NORWEST VENTURE PARTNERS XI, LP","position":1,"cik":"0001534522","reported_name":"Norwest Venture Partners XI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":2,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":3,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":4,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E Convertible Preferred Stock","published_at":"2019-07-29T21:02:26.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":424568,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The securities shown on Line 1 of Table I and Lines 1 through 5 of Table II represent securities held of record by Norwest Venture Partners XI, LP (\"NVP XI\"). Genesis VC Partners XI, LLC (\"Genesis XI\") is the general partner of NVP XI and may be deemed to have sole voting and dispositive power over the shares held by NVP XI. NVP Associates, LLC (\"NVP Associates\"), the managing member of Genesis XI, and Jeffrey Crowe and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities, Crowe and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":424568},"source":{"system":"sec-edgar","filing":"0001209191-19-043590","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1534522/000120919119043590/doc4.xml","form_type":"4"}},{"id":3454144,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":106341,"kind":"organization","name":"NORWEST VENTURE PARTNERS XI, LP","position":1,"cik":"0001534522","reported_name":"Norwest Venture Partners XI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":2,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":3,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":4,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Convertible Preferred Stock","published_at":"2019-07-29T21:02:26.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":471832,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The securities shown on Line 1 of Table I and Lines 1 through 5 of Table II represent securities held of record by Norwest Venture Partners XI, LP (\"NVP XI\"). Genesis VC Partners XI, LLC (\"Genesis XI\") is the general partner of NVP XI and may be deemed to have sole voting and dispositive power over the shares held by NVP XI. NVP Associates, LLC (\"NVP Associates\"), the managing member of Genesis XI, and Jeffrey Crowe and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities, Crowe and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":471832},"source":{"system":"sec-edgar","filing":"0001209191-19-043590","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1534522/000120919119043590/doc4.xml","form_type":"4"}},{"id":3454143,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":106341,"kind":"organization","name":"NORWEST VENTURE PARTNERS XI, LP","position":1,"cik":"0001534522","reported_name":"Norwest Venture Partners XI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":2,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":3,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":4,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2019-07-29T21:02:26.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":577045,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The securities shown on Line 1 of Table I and Lines 1 through 5 of Table II represent securities held of record by Norwest Venture Partners XI, LP (\"NVP XI\"). Genesis VC Partners XI, LLC (\"Genesis XI\") is the general partner of NVP XI and may be deemed to have sole voting and dispositive power over the shares held by NVP XI. NVP Associates, LLC (\"NVP Associates\"), the managing member of Genesis XI, and Jeffrey Crowe and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities, Crowe and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":577045},"source":{"system":"sec-edgar","filing":"0001209191-19-043590","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1534522/000120919119043590/doc4.xml","form_type":"4"}},{"id":3454142,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":106341,"kind":"organization","name":"NORWEST VENTURE PARTNERS XI, LP","position":1,"cik":"0001534522","reported_name":"Norwest Venture Partners XI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":2,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":3,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":4,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2019-07-29T21:02:26.000Z","date":"2019-07-29","kind":"exercise","acquired":false,"shares":1442727,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The securities shown on Line 1 of Table I and Lines 1 through 5 of Table II represent securities held of record by Norwest Venture Partners XI, LP (\"NVP XI\"). Genesis VC Partners XI, LLC (\"Genesis XI\") is the general partner of NVP XI and may be deemed to have sole voting and dispositive power over the shares held by NVP XI. NVP Associates, LLC (\"NVP Associates\"), the managing member of Genesis XI, and Jeffrey Crowe and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities, Crowe and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Series B Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series B Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series B Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1442727},"source":{"system":"sec-edgar","filing":"0001209191-19-043590","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1534522/000120919119043590/doc4.xml","form_type":"4"}},{"id":3454141,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":106341,"kind":"organization","name":"NORWEST VENTURE PARTNERS XI, LP","position":1,"cik":"0001534522","reported_name":"Norwest Venture Partners XI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":2,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":3,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":4,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-07-29T21:02:26.000Z","date":"2019-07-29","kind":"exercise","acquired":true,"shares":2952090,"ownership":{"direct":false,"nature":"By Limited Partnership"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series B Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The Series F Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"The securities shown on Line 2 of Table I and Lines 6 through 10 of Table II represent securities held of record by Norwest Venture Partners XII, LP (\"NVP XII\"). Genesis VC Partners XII, LLC (\"Genesis XII\") is the general partner of NVP XII and may be deemed to have sole voting and dispositive power over the shares held by NVP XII. NVP Associates, LLC (\"NVP Associates\"), the managing member of Genesis XII, and Jeffrey Crowe and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities, Crowe and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."}],"balance_after":2952090,"source":{"system":"sec-edgar","filing":"0001209191-19-043590","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534522/000120919119043590/doc4.xml","form_type":"4"}},{"id":3454140,"issuer":{"id":1565,"kind":"organization","name":"Health Catalyst, Inc.","symbol":"HCAT"},"owners":[{"id":106341,"kind":"organization","name":"NORWEST VENTURE PARTNERS XI, LP","position":1,"cik":"0001534522","reported_name":"Norwest Venture Partners XI, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":105624,"kind":"organization","name":"Norwest Venture Partners XII, LP","position":2,"cik":"0001614660","reported_name":"Norwest Venture Partners XII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":3,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":4,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-07-29T21:02:26.000Z","date":"2019-07-29","kind":"exercise","acquired":true,"shares":2952091,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The securities shown on Line 1 of Table I and Lines 1 through 5 of Table II represent securities held of record by Norwest Venture Partners XI, LP (\"NVP XI\"). Genesis VC Partners XI, LLC (\"Genesis XI\") is the general partner of NVP XI and may be deemed to have sole voting and dispositive power over the shares held by NVP XI. NVP Associates, LLC (\"NVP Associates\"), the managing member of Genesis XI, and Jeffrey Crowe and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities, Crowe and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series B Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Series D Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The Series E Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The Series F Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."}],"balance_after":2952091,"source":{"system":"sec-edgar","filing":"0001209191-19-043590","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534522/000120919119043590/doc4.xml","form_type":"4"}},{"id":3558748,"issuer":{"id":87417,"kind":"organization","name":"Silk Road Medical Inc","symbol":"SILK"},"owners":[{"id":105623,"kind":"organization","name":"Norwest Venture Partners XIII, LP","position":1,"cik":"0001772583","reported_name":"Norwest Venture Partners XIII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":2,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":3,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114424,"kind":"person","name":"HAQUE PROMOD","position":4,"cik":"0001089744","reported_name":"HAQUE PROMOD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (Right to buy)","published_at":"2019-04-10T18:31:33.000Z","date":"2019-04-08","kind":"other","acquired":false,"shares":3764,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The securities shown on Lines 1 and 2 of Table I and Lines 1 and 2 of Table II represent securities held of record by Norwest Venture Partners XIII, LP (\"NVP XIII\"). Genesis VC Partners XIII, LLC (\"Genesis XIII\") is the general partner of NVP XIII and may be deemed to have sole voting and dispositive power over the shares held by NVP XIII. NVP Associates, LLC (\"NVP Associates\"), the managing member of Genesis XIII, and Promod Haque, Jeffrey Crowe and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities and Haque, Crowe, and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"All of the shares subject to the warrant are fully exercisable as of the date hereof."}],"balance_after":0,"derivative":{"exercise_price":8.27,"expiration_date":"2024-12-21","underlying":"Common Stock","underlying_shares":3764},"source":{"system":"sec-edgar","filing":"0001209191-19-024306","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1089744/000120919119024306/doc4.xml","form_type":"4"}},{"id":3558747,"issuer":{"id":87417,"kind":"organization","name":"Silk Road Medical Inc","symbol":"SILK"},"owners":[{"id":105623,"kind":"organization","name":"Norwest Venture Partners XIII, LP","position":1,"cik":"0001772583","reported_name":"Norwest Venture Partners XIII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":2,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":3,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114424,"kind":"person","name":"HAQUE PROMOD","position":4,"cik":"0001089744","reported_name":"HAQUE PROMOD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Preferred Stock","published_at":"2019-04-10T18:31:33.000Z","date":"2019-04-08","kind":"exercise","acquired":false,"shares":2458210,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The securities shown on Lines 1 and 2 of Table I and Lines 1 and 2 of Table II represent securities held of record by Norwest Venture Partners XIII, LP (\"NVP XIII\"). Genesis VC Partners XIII, LLC (\"Genesis XIII\") is the general partner of NVP XIII and may be deemed to have sole voting and dispositive power over the shares held by NVP XIII. NVP Associates, LLC (\"NVP Associates\"), the managing member of Genesis XIII, and Promod Haque, Jeffrey Crowe and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities and Haque, Crowe, and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Series C Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series C Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series C Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2458210},"source":{"system":"sec-edgar","filing":"0001209191-19-024306","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1089744/000120919119024306/doc4.xml","form_type":"4"}},{"id":3558746,"issuer":{"id":87417,"kind":"organization","name":"Silk Road Medical Inc","symbol":"SILK"},"owners":[{"id":105623,"kind":"organization","name":"Norwest Venture Partners XIII, LP","position":1,"cik":"0001772583","reported_name":"Norwest Venture Partners XIII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":2,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":3,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114424,"kind":"person","name":"HAQUE PROMOD","position":4,"cik":"0001089744","reported_name":"HAQUE PROMOD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-04-10T18:31:33.000Z","date":"2019-04-08","kind":"other","acquired":true,"shares":3764,"price":8.27,"value":31128.28,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The securities shown on Lines 1 and 2 of Table I and Lines 1 and 2 of Table II represent securities held of record by Norwest Venture Partners XIII, LP (\"NVP XIII\"). Genesis VC Partners XIII, LLC (\"Genesis XIII\") is the general partner of NVP XIII and may be deemed to have sole voting and dispositive power over the shares held by NVP XIII. NVP Associates, LLC (\"NVP Associates\"), the managing member of Genesis XIII, and Promod Haque, Jeffrey Crowe and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities and Haque, Crowe, and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."}],"balance_after":2461974,"source":{"system":"sec-edgar","filing":"0001209191-19-024306","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1089744/000120919119024306/doc4.xml","form_type":"4"}},{"id":3558745,"issuer":{"id":87417,"kind":"organization","name":"Silk Road Medical Inc","symbol":"SILK"},"owners":[{"id":105623,"kind":"organization","name":"Norwest Venture Partners XIII, LP","position":1,"cik":"0001772583","reported_name":"Norwest Venture Partners XIII, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114423,"kind":"person","name":"Crowe Jeffrey","position":2,"cik":"0001535261","reported_name":"Crowe Jeffrey","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114425,"kind":"person","name":"Kossow Jon Erik","position":3,"cik":"0001726084","reported_name":"Kossow Jon Erik","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":114424,"kind":"person","name":"HAQUE PROMOD","position":4,"cik":"0001089744","reported_name":"HAQUE PROMOD","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-04-10T18:31:33.000Z","date":"2019-04-08","kind":"exercise","acquired":true,"shares":2458210,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The securities shown on Lines 1 and 2 of Table I and Lines 1 and 2 of Table II represent securities held of record by Norwest Venture Partners XIII, LP (\"NVP XIII\"). Genesis VC Partners XIII, LLC (\"Genesis XIII\") is the general partner of NVP XIII and may be deemed to have sole voting and dispositive power over the shares held by NVP XIII. NVP Associates, LLC (\"NVP Associates\"), the managing member of Genesis XIII, and Promod Haque, Jeffrey Crowe and Jon E. Kossow, as Co-Chief Executive Officers of NVP Associates, may be deemed to share voting and dispositive power with respect to such securities. Such entities and Haque, Crowe, and Kossow disclaim beneficial ownership of all such securities, except to the extent of any pecuniary interest therein."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series C Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and has no expiration date."}],"balance_after":2458210,"source":{"system":"sec-edgar","filing":"0001209191-19-024306","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1089744/000120919119024306/doc4.xml","form_type":"4"}}]}